A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin-Reference-Cited by-同舟云学术

A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin

Published:2018-06-29 Issue:3 Volume:119 Page:291-295
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Zheng Yi,Tu Xiaoxuan,Zhao Peng,Jiang Weiqin,Liu Lulu,Tong Zhou,Zhang Hangyu,Yan Cong,Fang Weijia,Wang Weilin

Funder

National Natural Science Foundation of China (National Science Foundation of China)

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-018-0138-2.pdf

Reference31 articles.

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA A Cancer J. Clin. 68, 7–30 (2018).

2. Razumilava, N. & Gores, G. J. Cholangiocarcinoma. Lancet 383, 2168–2179 (2014).

3. Misra, S., Chaturvedi, A., Misra, N. C. & Sharma, I. D. Carcinoma of the gallbladder. Lancet Oncol. 4, 167–176 (2003).

4. Okusaka, T. et al. Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer. Cancer Chemother. Pharmacol. 57, 647–653 (2006).

5. Yonemoto, N. et al. A multi-centre retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer. Jpn. J. Clin. Oncol. 37, 843–851 (2007).

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese national clinical practice guideline on diagnosis and treatment of biliary tract cancers;Chinese Medical Journal;2024-09-04

2. Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity;ESMO Open;2024-08

3. Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (AFEF);Liver International;2024-07-05

4. Treatment of Metastatic Biliary Cancers With Irinotecan and 5-Fluorouracil Based Chemotherapy After Platinum/Gemcitabine Progression: A Systematic Review and Meta-Analysis;Clinical Colorectal Cancer;2024-06

5. Treatment options for biliary tract cancer: unmet needs, new targets and opportunities from both physicians' and patients' perspectives;Future Oncology;2024-05-30